Norgine Ventures Announces Successful Conclusion of its Investment in Innovative Pharma Company Internis

London. 12 January 2015, 09.00 AM GMT.  Norgine Ventures today announced that it has successfully exited its investment in Internis Pharmaceuticals Limited following the acquisition of Internis by an undisclosed pharmaceutical company in December 2014. This transaction represents a significant achievement for this exciting and innovative British company. Internis, founded in 2010 by Charles Tannenbaum, […]

Norgine Ventures completes €4 million financing with SpineVision SA

London. 3 November 2014, 07:00 AM BST. Norgine Ventures today announced that it has provided financing of €4 million to SpineVision SA. The financing was realised in form of private bonds with warrants. Norgine Ventures is a business entity of Norgine, a European specialist pharmaceutical company. Norgine Ventures’ investment will help SpineVision finance development of […]

Norgine Ventures completes €7 million financing with Azanta Danmark A/S

London. Monday 13 October 2014. 07:00 AM BST. Norgine Ventures today announced that it has provided financing of up to €7million to Azanta Danmark A/S. This investment recognises the growth prospects of Azanta, a specialty pharma company marketing oncology, women’s health and addiction medicine products. The funding will help Azanta finance its late-stage clinical development […]

Norgine Ventures Completes €15 Million Financing With Agendia N.V.

London. 14 March 2014. Norgine Ventures today announced that, together with a number of Agendia’s existing shareholders, it has provided debt financing of €15 million to Agendia NV, with Norgine leading the syndicate. This investment recognises the growth prospects of Agendia, a molecular diagnostic company marketing a suite of breast and colon cancer tests. The […]

Norgine Ventures Completes €5 Million Financing With Supersonic Imagine SA

London. 10 January 2014. Norgine Ventures today announced that it has provided financing of €5 million to SuperSonic Imagine SA. The financing was realised in form of private bonds with warrants. Norgine Ventures’ investment will enable SuperSonic Imagine to accelerate further technological development and commercial expansion in the US and in Asia. Norgine Ventures is […]

Norgine Ventures Completes £7.5 Million Debt Financing With Stanmore Implants

London. 13 December 2013, 07:00 AM GMT. Norgine Ventures today announced that it has provided debt financing of £7.5 million to Stanmore Implants Worldwide Ltd. This funding recognises the potential of Stanmore Implants, a pioneer in the global limb salvage and preservation orthopaedic implants markets. Norgine Ventures is a business entity of Norgine, a well-established […]